Last reviewed · How we verify
NCT06372613
Association Between LRG and Histologic Remission in Ulcerative Colitis
trial in Ulcerative Colitis in Histologic Remission in 100 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Showa Inan General Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 25 February 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Japan |
Conditions studied
- Ulcerative Colitis in Histologic Remission — all drugs for Ulcerative Colitis in Histologic Remission →
Sponsor
Showa Inan General Hospital
Who can join
Adults 20 to 90, any sex, with Ulcerative Colitis in Histologic Remission. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed when histologic remission is predicted, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06372613
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Showa Inan General Hospital trials
Trials by the same sponsor.
- NCT07243639 — Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis · NA · recruiting
- NCT06626165 — Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of th · Phase 4 · completed
- NCT05930041 — Injured Submucosal Arteries After CSP for 10-19 mm Nonpedunculated Colorectal Polyps. · NA · completed
- NCT05213208 — Safety of Propofol Sedation ( > 200 mg) for Colonoscopy. · completed
- NCT04720781 — The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06372613 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Showa Inan General Hospital
- Last refreshed: 22 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06372613.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing